Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer.
Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer.
复制标题
DOI:
10.1186/1749-8090-8-106
复制
发表时间:
2013-04-22
影响因子:
1.6
通讯作者:
Nakajima T
中科院分区:
文献类型:
--
作者:
Kozu Y;Maniwa T;Takahashi S;Isaka M;Ohde Y;Nakajima T
Until date, there are no clear recommendations for regular perioperative measurements of serum CEA levels for lung cancer in any guidelines. The purpose in the present study is to evaluate the prognostic significance of perioperative serum carcinoembryonic antigen (CEA) levels in patients with pathological-stage I non-small cell lung cancer (NSCLC). We retrospectively reviewed 263 completely resected pathological-stage I NSCLC patients whose preoperative and postoperative serum CEA levels were measured. Patients were subdivided according to the perioperative change of CEA levels: continuously normal CEA levels (NN group), continuously high CEA levels (HH group), and high preoperative CEA levels that returned to normal levels post-operation (HN group). The clinicopathological factors and overall survival (OS) among these 3 groups were compared. Univariate and multivariate analyses of the correlation between clinicopathological factors and OS were performed. High preoperative CEA levels significantly correlated with men aged >70 years with smoking history, high serum CYFRA 21–1 levels, greater tumor diameter, presence of visceral pleural invasion (VPI), and moderate-to-poor differentiation. Five-year OS rates in the NN and HH groups were 95.5% and 59.3%, respectively. Four-year OS rate in the HN group was 85.5%. Multivariate analyses indicated tumor diameter of more than 30 mm, presence of VPI, and the HH group were independent unfavorable prognostic factors. A high postoperative CEA level was an independent unfavorable prognostic factor in pathological-stage I NSCLC patients. Patients with high postoperative CEA levels may benefit from adjuvant chemotherapy.
登录
查看更多内容
影响因子:
4.6
作者:
Buccheri, G;Ferrigno, D
通讯作者:
Ferrigno, D
影响因子:
4.6
作者:
Sawabata, N;Ohta, M;Maeda, H
通讯作者:
Maeda, H
影响因子:
2.6
作者:
Kosugi, S;Nishimaki, T;Hatakeyama, K
通讯作者:
Hatakeyama, K
DOI:
10.1016/j.jtcvs.2005.12.035
发表时间:
2006-05-01
影响因子:
6
作者:
Inoue, M;Minami, M;Okumura, M
通讯作者:
Okumura, M
影响因子:
20.4
作者:
Goldstraw, Peter;Crowley, John;Sobin, Leslie
通讯作者:
Sobin, Leslie